Results from a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-CD19 (LV20.19) CAR T-Cells for Mantle Cell Lymphoma
- Resource Type
- Source
- Transplantation and Cellular Therapy. 29:S33-S34
- Subject
Transplantation Immunology Molecular Medicine Immunology and Allergy Cell Biology Hematology Biochemistry - Language
- ISSN
- 2666-6367